Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer

    Machine learning (ML) models presented an excellent performance in the prognosis prediction. However, the black box characteristic of ML models limited the clinical applications. Here, we aimed to establish ex...

    Wenhao Lu, Lin Zhao, Shenfan Wang, Huiyong Zhang in Clinical and Translational Oncology (2024)

  2. No Access

    Article

    Immune checkpoint inhibitor-associated adrenal insufficiency in Chinese cancer patients: a retrospective analysis

    Immune checkpoint inhibitors (ICIs) are of great success in cancer therapy. This study aimed to identify adrenal insufficiency (AI) associated with immune checkpoint inhibitor (ICI) treatment in cancer patient...

    Qingqing Cai, Wei Wu, **aoyu Li, Qing Xu in Journal of Cancer Research and Clinical On… (2023)

  3. No Access

    Article

    Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors

    Identifying patients at increased risk of immune-related adverse events (irAEs) facilitates safe application of immune checkpoint inhibitors (ICIs). This retrospective study aimed to determine the effect of ag...

    Kaili Yang, Jiarui Li, Zhao Sun, Chunmei Bai in Clinical and Experimental Medicine (2023)

  4. No Access

    Article

    Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review

    This article describes a potential treatment for early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), a relatively rare and highly aggressive hematologic malignancy. A 59-year-old woman admitted to o...

    Yihan Zhao, Shiqing Jiang, Yujun Tang, Lin Zhao in International Journal of Hematology (2023)

  5. Article

    Open Access

    Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial

    Treatment options for pretreated triple-negative breast cancer (TNBC) are limited. This study aimed to evaluate the efficacy and safety of apatinib, an antiangiogenic agent, in combination of etoposide for pre...

    Mengru Cao, Hailing Lu, Shi Yan, Hui Pang, Lichun Sun, Chunhong Li in BMC Cancer (2023)

  6. Article

    Correction: Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis

    Ji-nuo Wang, Ting Liu, Ai-lin Zhao, Bo-ju Pan, Jian Sun, Jian Li, Dao-bin Zhou in Leukemia (2023)

  7. No Access

    Article

    Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy

    It is well-established that the lack of accurate diagnostic modalities for prostate cancer (PCa) leads to overdiagnosis and overtreatments. Accordingly, this study aimed to assess the value of urine-derived ex...

    Cheng-Bang Wang, Shao-Hua Chen, Lin Zhao, **n ** in Clinical and Translational Oncology (2023)

  8. Article

    Open Access

    Correction: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance

    Longlong **e, Feng Shi, Yueshuo Li, We Li in Signal Transduction and Targeted Therapy (2022)

  9. Article

    Open Access

    The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

    Given that hypoxia is a persistent physiological feature of many different solid tumors and a key driver for cancer malignancy, it is thought to be a major target in cancer treatment recently. Tumor-associated...

    Ruixue Bai, Yunong Li, Lingyan Jian, Yuehui Yang, Lin Zhao, Minjie Wei in Molecular Cancer (2022)

  10. No Access

    Article

    Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis

    Langerhans cell histiocytosis (LCH) is a clonal histiocytic neoplasm with various clinical manifestations and heterogeneous prognoses. No standard therapy is available for recurrent/refractory LCH patients. Th...

    Ji-nuo Wang, Ting Liu, Ai-lin Zhao, Bo-ju Pan, Jian Sun, Jian Li, Dao-bin Zhou in Leukemia (2022)

  11. Article

    Open Access

    Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

    Treatment strategies are limited for patients with chemotherapy refractory microsatellite stable (MSS) colorectal cancer. We aim to evaluate the efficacy and safety of immune checkpoint inhibitors (ICIs) combi...

    Kaili Yang, Lu Han, Shikai Wu, **ujuan Qu, Qin Li in Cancer Immunology, Immunotherapy (2022)

  12. No Access

    Article

    Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people

    The incidence and mortality of gastrointestinal (GI) tumors are high in China. Some studies suggest that the gut microbiota is related to the occurrence and development of tumors. At present, there are no pros...

    Ningning Li, Chunmei Bai, Lin Zhao, Yu** Ge in Clinical and Translational Oncology (2022)

  13. Article

    Open Access

    Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives

    Cancer is a type of malignant affliction threatening human health worldwide; however, the molecular mechanism of cancer pathogenesis remains to be elusive. The oncogenic hedgehog (Hh) pathway is a highly evolu...

    Jia Song, Yuexin Ge, **aoyu Sun, Qiutong Guan, Shiqiang Gong in Molecular Cancer (2022)

  14. No Access

    Article

    The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim–Chester disease in adults

    Ai-lin Zhao, Hao Cai, Jia Chen, Ming-hui Duan, Dao-bin Zhou, Jian Li in Leukemia (2022)

  15. No Access

    Article

    ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy

    The impact of activating transcription factor 4 (ATF4), differentially expressed in colorectal cancer (CRC), on 5-Fluorouracil (5-FU) chemoresistance has not been fully explained. The purpose of this study is ...

    Lin Zhao, Hong Chen, QingYi Zhang, ** Ma, Hao Hu in Cancer Chemotherapy and Pharmacology (2022)

  16. Article

    Open Access

    Targeted protein degradation: mechanisms, strategies and application

    Traditional drug discovery mainly focuses on direct regulation of protein activity. The development and application of protein activity modulators, particularly inhibitors, has been the mainstream in drug deve...

    Lin Zhao, Jia Zhao, Kunhong Zhong, Ai** Tong in Signal Transduction and Targeted Therapy (2022)

  17. Article

    Open Access

    Clinical significance of FBXW7 loss of function in human cancers

    FBXW7 (F-Box and WD Repeat Domain Containing 7) (also referred to as FBW7 or hCDC4) is a component of the Skp1-Cdc53 / Cullin-F-box-protein complex (SCF/β-TrCP). As a member of the F-box protein family, FBXW7 ...

    **gyi Fan, Marcia Bellon, Mingyi Ju, Lin Zhao, Minjie Wei, Liwu Fu in Molecular Cancer (2022)

  18. Article

    Open Access

    Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)

    Lin Zhao, Yan Wang, Longyang Jiang, Miao He in Journal of Experimental & Clinical Cancer … (2022)

  19. No Access

    Article

    LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer

    Insulin-like growth factor-2 mRNA-binding protein 2 (IGF2BP2, also known as IMP2), a novel class III N6-methyladenosine (m6A) reader, has recently gained attention due to its critical functions in recognizing and...

    Huizhe Wu, **angyu Ding, **aoyun Hu, Qing Zhao, Qiuchen Chen, Tong Sun in Oncogene (2022)

  20. No Access

    Article

    Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

    Jia Chen, Ai-lin Zhao, Ming-hui Duan, Hao Cai, Xue-min Gao, Ting Liu, Jian Sun in Leukemia (2022)

previous disabled Page of 4